Mirxes Announces NMPA Approval for GASTROClear™ in China, Paving the Way for Major Launch in Key Market
October 9, 2025
First-in-Class Approval: GASTROClear™ becomes the first non-invasive blood test approved for the screening of gastric cancer in China. Massive Market Opportunity: The test is approved for high-risk adults aged 45